Mannkind Corporation
Nasdaq MNKD · Danbury, CT
Works in Immunology · Metabolic & endocrine · Respiratory
Mannkind Corporation is a clinical trial sponsor based in Danbury, CT, listed as Nasdaq MNKD. It has 2 active clinical trials with 253 planned participants, in Immunology, Metabolic & endocrine and Respiratory. Since 2021 it has completed 6 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq MNKD
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Mannkind Corporation
Mannkind Corporation is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 253 planned participants, in Immunology, Metabolic & endocrine, Respiratory. Since 2021 it has completed 6 trials and stopped 1 early.
Mannkind Corporation is based in Danbury, CT and is listed as Nasdaq MNKD. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Mannkind Corporation; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-14.
Approve Suite is not affiliated with Mannkind Corporation.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.